| Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed) |
National Institutes of Health |
posted |
05/25/2029 |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) |
National Institutes of Health |
posted |
02/11/2027 |
| Specialized Alcohol Research Centers (P50 Clinical trial Optional) |
National Institutes of Health |
posted |
01/27/2027 |
| Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
posted |
02/11/2027 |
| Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required) |
National Institutes of Health |
posted |
11/17/2026 |
| Assessing the Feasibility of Incorporating Mechanisms in Multi-site Clinical Trials of Mind and Body Interventions on Whole Person Health Restoration (R33 Clinical Trial Required) |
National Institutes of Health |
posted |
11/16/2029 |
| Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional) |
National Institutes of Health |
posted |
10/11/2029 |
| Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required) |
National Institutes of Health |
posted |
09/25/2029 |
| NIH Research Program Projects (Parent P01 Clinical Trial Optional) |
National Institutes of Health |
posted |
05/25/2029 |
| Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional) |
National Institutes of Health |
posted |
11/05/2029 |
| Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional) |
National Institutes of Health |
posted |
09/26/2029 |
| Testing Centers for Evaluation of Somatic Cell Genome Editing Approaches for Translational Applications (U42 Clinical Trial Not Allowed) |
National Institutes of Health |
forecasted |
10/13/2026 |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) |
National Institutes of Health |
posted |
02/11/2027 |
| Coordinating Center for the Claude D. Pepper Older Americans Independence Centers (OAICs) |
National Institutes of Health |
forecasted |
10/13/2026 |
| Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
posted |
02/09/2027 |
| Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
posted |
11/23/2026 |
| NIAMS P30 Centers Program (P30 - Clinical Trial Not Allowed) |
National Institutes of Health |
posted |
03/01/2029 |
| Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed) |
National Institutes of Health |
posted |
11/23/2026 |
| Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed) |
National Institutes of Health |
posted |
11/23/2026 |
| Chronic Disease Education and Awareness |
Centers for Disease Control - NCCDPHP |
forecasted |
10/09/2026 |
| Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed) |
National Institutes of Health |
posted |
10/13/2028 |
| Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
posted |
02/08/2027 |
| Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed) |
National Institutes of Health |
posted |
12/14/2026 |
| Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed) |
National Institutes of Health |
posted |
12/14/2026 |
| Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed) |
National Institutes of Health |
posted |
12/14/2026 |